Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Mesh:Signal Transduction*/drug effects"" wg kryterium: Temat


Tytuł :
Oligogalacturonic Acid Inhibits Vascular Calcification by Two Mechanisms Inhibition of Vascular Smooth Muscle Cell Osteogenic Conversion and Interaction With Collagen
Autorzy :
Hodroge, Ahmed
Trecherel, Eric
Cornu, Marjorie
Darwiche, Walaa
Mansour, Ali
Ait-Mohand, Katia
Verissimo, Thomas
Gomila, Cathy
Schembri, Carole
Da Nascimento, Sophie
Elboutachfaiti, Redouan
Boullier, Agnes
Lorne, Emmanuel
Courtois, Josiane
Petit, Emmanuel
Toumieux, Sylvestre
Kovensky, Jose
Sonnet, Pascal
Massy Ziad, A
Kamel, Said
Rossi, Claire
Ausseil, Jerome
Pokaż więcej
Temat :
Mesh:Binding Sites
Mesh:Tissue Culture Techniques
Mesh:Collagen Type I/metabolism
Mesh:Osteogenesis/drug effects
Mesh:Rats
Mesh:Wistar
Mesh:Vascular Calcification/prevention & control
Mesh:Myocytes
Mesh:Smooth Muscle/pathology
Mesh:Extracellular Vesicles/drug effects
Mesh:Smooth Muscle/drug effects
Mesh:Oligosaccharides/pharmacology
Mesh:Protein Binding
Mesh:Calcium/metabolism
Mesh:Signal Transduction/drug effects
Mesh:Aorta
Mesh:Thoracic/drug effects
Mesh:Crystallization
Mesh:Thoracic/metabolism
Mesh:Aortic Diseases/metabolism
Mesh:Vascular Calcification/metabolism
Mesh:Muscle
Mesh:Smooth
Mesh:Vascular/drug effects
Mesh:Mice
Mesh:Animals
Mesh:Vascular/pathology
Mesh:Extracellular Vesicles/metabolism
Mesh:Vascular/metabolism
Mesh:Aortic Diseases/prevention & control
Mesh:Thoracic/pathology
Mesh:Cell Transdifferentiation/drug effects
Mesh:Protein Interaction Domains and Motifs
Mesh:Male
Mesh:Cells
Mesh:Cultured
Mesh:Biomarkers/metabolism
Mesh:Smooth Muscle/metabolism
Mesh:Dose-Response Relationship
Mesh:Drug
Mesh:Vascular Calcification/pathology
Mesh:Aortic Diseases/pathology
oligogalacturonic acid
type I collagen
matrix vesicle
vascular calcification
Sciences du Vivant [q-bio]
Tytuł :
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-alpha and -delta, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Autorzy :
Ratziu, Vlad
Harrison, Stephen
Francque, Sven
Bedossa, Pierre
Lehert, Philippe
Serfaty, Lawrence
Romero-Gomez, Manuel
Boursier, Jerome
Abdelmalek, Manal
Caldwell, Steve
Drenth, Joost
Anstee, Quentin
Hum, Dean
Hanf, Remy
Roudot, Alice
Megnien, Sophie
Staels, Bart
Sanyal, Arun
Pokaż więcej
Temat :
Mesh:Middle Aged
Mesh:Non-alcoholic Fatty Liver Disease/pathology
Mesh:Time Factors
Mesh:Humans
Mesh:Propionates/administration & dosage
Mesh:Biopsy
fatty liver
Mesh:Chalcones/administration & dosage
PPARD
PPARA
Mesh:Intention to Treat Analysis
Mesh:Non-alcoholic Fatty Liver Disease/complications
Sciences du Vivant [q-bio]
Mesh:PPAR alpha/metabolism
Mesh:Treatment Outcome
Mesh:Liver Cirrhosis/etiology
Mesh:Propionates/adverse effects
Mesh:Liver/metabolism
Mesh:Signal Transduction/drug effects
Mesh:PPAR alpha/agonists
Mesh:Logistic Models
Mesh:Adult
Mesh:Remission Induction
Mesh:Liver/pathology
Mesh:Chalcones/adverse effects
Mesh:Gastrointestinal Agents/administration & dosage
Mesh:Non-alcoholic Fatty Liver Disease/drug therapy
Mesh:Severity of Illness Index
Mesh:Gastrointestinal Agents/adverse effects
Mesh:Biomarkers/blood
Mesh:Non-alcoholic Fatty Liver Disease/metabolism
Mesh:Liver/drug effects
Mesh:PPAR gamma/metabolism
NAFLD
Mesh:PPAR gamma/agonists
Mesh:Female
Mesh:United States
Mesh:Odds Ratio
Mesh:Europe
Mesh:Male
Mesh:Double-Blind Method

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies